Trial
NCT02664753
L-carnitine as an Adjunct Treatment for Septic Shock Patients With Acute Kidney Injury
Phase IIITERMINATEDSAFETYConfidence: HIGH
Sponsor
Centre Hospitalier Universitaire de Nīmes
Collaborators
—
Condition
Severe Sepsis
Intervention
56 days of weight-adjusted L-Carnitine treatment
Why stopped
Exposure to serious adverse events related to the research (i.e., death), the mnts = 54% versus 58 deaths out of 121 patients = 48%).onitoring committee unanimously recommended discontinuation of the trial.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-08-26